Rabbit Polyclonal TRA2A antibody. Suitable for IP, WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human TRA2A aa 1-50.
View Alternative Names
Transformer-2 protein homolog alpha, TRA-2 alpha, TRA2-alpha, Transformer-2 protein homolog A, TRA2A
- IP
Unknown
Immunoprecipitation - Anti-TRA2A antibody (AB138448)
Immunoprecipitation detection of TRA2A in HeLa whole cell lysate (1 mg/IP; 20% of IP loaded/lane) using ab138448 at 6µg/mg lysate. Subsequent Western blot detection step was performed using ab138448 at 0.4µg/ml. Chemiluminescence with an exposure time of 30 seconds.
All lanes:
Immunoprecipitation - Anti-TRA2A antibody (ab138448)
Predicted band size: 33 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-TRA2A antibody (AB138448)
ab138448 at 6 μg/mg of lysate immunoprecipitating TRA2A in HeLa (human cervix adenocarcinoma) whole cell lysate.
Lane 1 : ab137248 + HeLa whole cell lysate (1 mg/IP; 20% of IP loaded/lane)
Lane 2 : ab138448 + HeLa whole cell lysate (1 mg/IP; 20% of IP loaded/lane)
Lane 3 (-) : Control IgG + HeLa whole cell lysate (1 mg/IP; 20% of IP loaded/lane)
For western blotting, ab138448 at 0.4 μg/mL
Detection : Chemiluminescence with exposure time of 10 seconds.
All lanes:
Immunoprecipitation - Anti-TRA2A antibody (ab138448)
Predicted band size: 33 kDa
false
- WB
Unknown
Western blot - Anti-TRA2A antibody (AB138448)
All lanes:
Western blot - Anti-TRA2A antibody (ab138448) at 1/2000 dilution
Lane 1:
HeLa cell lysate at 50 µg
Lane 2:
HeLa cell lysate at 15 µg
Lane 3:
293T cell lysate at 50 µg
Lane 4:
Jurkat cell lysate at 50 µg
Predicted band size: 33 kDa
true
Exposure time: 30s
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TRA2A influences gene expression and transcript variants by engaging in complex interactions. It acts as part of the spliceosome machinery which is a large ribonucleoprotein complex responsible for splicing pre-mRNA. TRA2A ensures precise removal of introns and ligation of exons producing different mRNA isoforms. These isoforms translate into functionally distinct proteins influencing cellular activity.
Pathways
TRA2A participates in the mRNA processing pathway influencing genetic output by regulating splice site selection. TRA2A connects to the MAPK signaling pathway as it is known to interact with proteins like SAM68 which also affects mRNA splicing. This connectivity with other proteins highlights the regulatory network's complexity ensuring accurate gene expression profiles.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
International journal of biological sciences 19:3678-3693 PubMed37564197
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasma 69:1322-1337 PubMed36264775
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com